BioVentrix Selected to Present at Prestigious EuroPCR Meeting Reuters PARIS--(Marketwire - May 14, 2012) - BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, was selected to present at EuroPCR, the annual meeting of the European Association for Percutaneous Cardiovascular ... |
